Kura Oncology (KURA) Depreciation & Amortization (CF) (2014 - 2026)
Kura Oncology (KURA) reported Depreciation & Amortization (CF) of $355000.0 for Q1 2026, up 47.3% year-over-year from $241000.0 in Q1 2025, and down 11.91% on a QoQ basis from $403000.0 in Q4 2025.
Kura Oncology (KURA) has 12 years of Depreciation & Amortization (CF) data on file, last reported at $355000.0 in Q1 2026.
- Quarterly Depreciation & Amortization (CF) rose 47.3% year-over-year to $355000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (up 42.01% YoY) and the FY2025 annual result came in at $1.0 million, up 29.0% from the prior year.
- Depreciation & Amortization (CF) declined to $355000.0 in Q1 2026 per KURA's latest filing, from $403000.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $403000.0 in Q4 2025 and bottomed at $156000.0 in Q4 2024.
- The 5-year median for Depreciation & Amortization (CF) is $208000.0 (2024), against an average of $222764.7.
- The widest annual swing landed in 2023, when Depreciation & Amortization (CF) plunged 33.2%; it then jumped 158.33% in 2025.
- Tracing KURA's Depreciation & Amortization (CF) over 5 years: stood at $247000.0 in 2022, then sank by 33.2% to $165000.0 in 2023, then slipped by 5.45% to $156000.0 in 2024, then surged by 158.33% to $403000.0 in 2025, then declined by 11.91% to $355000.0 in 2026.
- Per Business Quant, the three latest KURA Depreciation & Amortization (CF) figures stand at $355000.0 (Q1 2026), $403000.0 (Q4 2025), and $164000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1,395.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 55.90 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 123.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 13.55 Mn |
| 10 | Kura Oncology | 801.92 Mn | 801.92 Mn | 18.00 Mn | 355,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 355,000.00 |
| Mar 31, 2026 | 355,000.00 |
| Dec 31, 2025 | 403,000.00 |
| Dec 31, 2025 | 403,000.00 |
| Sep 30, 2025 | 164,000.00 |
| Sep 30, 2025 | 164,000.00 |
| Jun 30, 2025 | 224,000.00 |
| Jun 30, 2025 | 224,000.00 |
| Mar 31, 2025 | 241,000.00 |
| Mar 31, 2025 | 241,000.00 |
| Dec 31, 2024 | 156,000.00 |
| Dec 31, 2024 | 156,000.00 |
| Sep 30, 2024 | 208,000.00 |
| Sep 30, 2024 | 208,000.00 |
| Jun 30, 2024 | 202,000.00 |
| Jun 30, 2024 | 202,000.00 |
| Mar 31, 2024 | 234,000.00 |
| Mar 31, 2024 | 234,000.00 |
| Dec 31, 2023 | 165,000.00 |
| Dec 31, 2023 | 165,000.00 |
| Sep 30, 2023 | 216,000.00 |
| Sep 30, 2023 | 216,000.00 |
| Jun 30, 2023 | 213,000.00 |
| Jun 30, 2023 | 213,000.00 |
| Mar 31, 2023 | 206,000.00 |
| Mar 31, 2023 | 206,000.00 |
| Dec 31, 2022 | 247,000.00 |
| Dec 31, 2022 | 247,000.00 |
| Sep 30, 2022 | 193,000.00 |
| Sep 30, 2022 | 193,000.00 |
| Jun 30, 2022 | 183,000.00 |
| Jun 30, 2022 | 183,000.00 |
| Mar 31, 2022 | 177,000.00 |
| Mar 31, 2022 | 177,000.00 |
| Dec 31, 2021 | 166,000.00 |
| Dec 31, 2021 | 166,000.00 |
| Sep 30, 2021 | 160,000.00 |
| Sep 30, 2021 | 160,000.00 |
| Jun 30, 2021 | 124,000.00 |
| Jun 30, 2021 | 124,000.00 |
| Mar 31, 2021 | 108,000.00 |
| Mar 31, 2021 | 108,000.00 |
| Dec 31, 2020 | 114,000.00 |
| Dec 31, 2020 | 114,000.00 |
| Sep 30, 2020 | 74,000.00 |
| Sep 30, 2020 | 74,000.00 |
| Dec 31, 2018 | -10,000.00 |
| Dec 31, 2018 | -10,000.00 |
| Sep 30, 2018 | 1,000.00 |
| Sep 30, 2018 | 1,000.00 |
| Jun 30, 2018 | 4,000.00 |
| Jun 30, 2018 | 4,000.00 |
| Mar 31, 2018 | 5,000.00 |
| Mar 31, 2018 | 5,000.00 |
| Dec 31, 2017 | 7,000.00 |
| Dec 31, 2017 | 7,000.00 |
| Sep 30, 2017 | 7,000.00 |
| Sep 30, 2017 | 7,000.00 |
| Jun 30, 2017 | 8,000.00 |
| Jun 30, 2017 | 8,000.00 |
| Mar 31, 2017 | 8,000.00 |
| Mar 31, 2017 | 8,000.00 |
| Dec 31, 2016 | 8,000.00 |
| Dec 31, 2016 | 8,000.00 |
| Sep 30, 2016 | 8,000.00 |
| Sep 30, 2016 | 8,000.00 |
| Jun 30, 2016 | 7,000.00 |
| Jun 30, 2016 | 7,000.00 |
| Mar 31, 2016 | 8,000.00 |
| Mar 31, 2016 | 8,000.00 |
| Dec 31, 2015 | 7,000.00 |
| Dec 31, 2015 | 7,000.00 |
| Sep 30, 2015 | 7,000.00 |
| Sep 30, 2015 | 7,000.00 |
| Jun 30, 2015 | 3,000.00 |
| Jun 30, 2015 | 3,000.00 |
| Mar 31, 2015 | 3,000.00 |
| Mar 31, 2015 | 3,000.00 |
| Dec 31, 2014 | 1,000.00 |
| Dec 31, 2014 | 1,000.00 |